Prognostic value of FDG, PSMA, and DOTATATE uptake on PET imaging in metastatic castration-resistant prostate cancer (mCRPC).

Authors

null

Frederic Pouliot

CHU de Québec - Université Laval, Québec, QC, Canada

Frederic Pouliot , Fred Saad , Étienne Rousseau , Patrick O. Richard , Atefeh Zamanian , Stephan Probst , Eric Levesque , Vincent Castonguay , Nicolas Marcoux , Daniel Juneau , Michele Lodde , Jean-Baptiste Lattouf , François-Alexandre Buteau , Zineb Hamilou , Michel Pavic , Jean-François Castilloux , Guillaume Bouvet , Amélie Tetu , Brigitte Guérin , Jean-Mathieu Beauregard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Diagnostics and Imaging

Clinical Trial Registration Number

NCT04000776

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 31)

DOI

10.1200/JCO.2024.42.4_suppl.31

Abstract #

31

Poster Bd #

A10

Abstract Disclosures

Similar Posters

First Author: Andrei Gafita

Poster

2024 ASCO Genitourinary Cancers Symposium

Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.

Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.

First Author: Ahmed M. Mahmoud

First Author: Ridvan Arda Demirci